Each tablet contains:
Active ingredient:
Chymotrypsine | 4200 USP units |
Treatment of post-operative, post-traumatic oedema, burn
Treatment of post-operative, post-traumatic oedema, burn.
POSOLOGY AND METHOD OF ADMINISTRATION
Oral: 2 tablets each time, 3 – 4 times daily, should be taken with plenty of water (at least 250 ml) to enhance enzyme activity.
Sublingual: 4 – 6 tablets daily in divided doses. Let the tablet slowly dissolve under the tongue.
CONTRAINDICATIONS
Hypersensitivity to chymotrypsin or any ingredient of drug.
Patients with decreased alpha-1 antitrypsin.
WARNINGS AND PRECAUTIONS
Caution should be taken in patients with the risk of alpha-1 antitrypsin deficiency: chronic obstructive pulmonary disease, especially emphysema and patients presenting with nephrotic syndrome.
The drug should not be used in patients with inherited blood clotting disorder such as hemophilia, blood clotting disorder, those taking anticoagulants, those who are just about to undergone surgery, anyone suffering from protein allergies, patients has stomach ulcers.
Excipient Warning:
The product contains aspartame which includes phenylalanine; therefore caution should be taken in patients with phenylketonuria.
SHELF-LIFE
36 months from the manufacturing date. Do not use after the expiry date
Box of 2 blisters x 10 tablets.
Box of 10 blisters x 10 tablets.